{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:19:19Z","timestamp":1779117559003,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fund for Scientific Research","award":["FWO\/G.0972.13"],"award-info":[{"award-number":["FWO\/G.0972.13"]}]},{"name":"KU Leuven In\u00a0Vivo Molecular Imaging (IMIR) Consortium","award":["KUL PF\/10\/017"],"award-info":[{"award-number":["KUL PF\/10\/017"]}]},{"name":"KU Leuven In\u00a0Vivo Molecular Imaging (IMIR) Consortium","award":["278850"],"award-info":[{"award-number":["278850"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.neurobiolaging.2014.06.010","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T20:00:53Z","timestamp":1402948853000},"page":"2858-2869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in\u00a0vivo in R6\/2 Huntington mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Maarten","family":"Ooms","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roma","family":"Rietjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaki Raman","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Vunckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Valdeolivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Himmelreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Fernandez-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-2232","authenticated-orcid":false,"given":"Cindy","family":"Casteels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","article-title":"Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease","volume":"37","author":"Allen","year":"2009","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib2","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1021\/jm200536d","article-title":"Synthesis, in\u00a0vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging","volume":"54","author":"Andres","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"issue":"Pt 6","key":"10.1016\/j.neurobiolaging.2014.06.010_bib3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington's disease","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib6","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1073\/pnas.0703472104","article-title":"[18F]MK-9470, a positron emission tomography (PET) tracer for in\u00a0vivo human PET brain imaging of the cannabinoid-1 receptor","volume":"104","author":"Burns","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib7","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-012-2163-3","article-title":"Preclinical evaluation and quantification of [(18)F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain","volume":"39","author":"Casteels","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2009.12.026","article-title":"In\u00a0vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease","volume":"1316","author":"Casteels","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib10","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1007\/s00259-010-1574-2","article-title":"Type 1 cannabinoid receptor mapping with [(18)F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism","volume":"37","author":"Casteels","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.expneurol.2011.03.014","article-title":"Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease","volume":"229","author":"Casteels","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib12","doi-asserted-by":"crossref","first-page":"e65286","DOI":"10.1371\/journal.pone.0065286","article-title":"Construction and evaluation of quantitative small-animal PET probabilistic atlases for [(1)(8)F]FDG and [(1)(8)F]FECT functional mapping of the mouse brain","volume":"8","author":"Casteels","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroimage.2013.04.123","article-title":"Preclinical evaluation of [F]JNJ42259152 as a PET tracer for PDE10A","volume":"82C","author":"Celen","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biopsych.2005.03.008","article-title":"Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6\/2 Huntington's disease mice","volume":"57","author":"Centonze","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jnc.12399","article-title":"Crosstalk between dopamine D2 receptors and cannabinoid CB1 receptors regulates CNR1 promoter activity via ERK1\/2 signaling","volume":"127","author":"Chiang","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nbd.2011.12.017","article-title":"Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease","volume":"45","author":"Chiodi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","article-title":"Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species","volume":"54","author":"Coskran","year":"2006","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib19","doi-asserted-by":"crossref","first-page":"e28409","DOI":"10.1371\/journal.pone.0028409","article-title":"Onset and progression of behavioral and molecular phenotypes in a novel congenic R6\/2 line exhibiting intergenerational CAG repeat stability","volume":"6","author":"Cowin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2012.04.015","article-title":"Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease","volume":"236","author":"Dougherty","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib24","doi-asserted-by":"crossref","first-page":"e13417","DOI":"10.1371\/journal.pone.0013417","article-title":"Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease","volume":"5","author":"Giampa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib25","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0163-7258(02)00250-4","article-title":"From cannabis to cannabinergics: new therapeutic opportunities","volume":"95","author":"Goutopoulos","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib30","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/ejn.12045","article-title":"Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models","volume":"37","author":"Horne","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib32","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","article-title":"Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A","volume":"20","author":"Hu","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.110.173294","article-title":"Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease","volume":"336","author":"Kleiman","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/NEN.0b013e3181d6c436","article-title":"Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease","volume":"69","author":"Klevytska","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00001756-200410250-00015","article-title":"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in\u00a0vivo","volume":"15","author":"Lastres-Becker","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/syn.10054","article-title":"Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease","volume":"44","author":"Lastres-Becker","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2012.11.016","article-title":"Phosphodiesterase 10A (PDE10A) localization in the R6\/2 mouse model of Huntington's disease","volume":"52","author":"Leuti","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1109\/42.974934","article-title":"Retrospective correction of MR intensity inhomogeneity by information minimization","volume":"20","author":"Likar","year":"2001","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib40","series-title":"Information Processing in Medical Imaging","first-page":"463","article-title":"Nonrigid image registration using a statistical spline deformation model","author":"Loeckx","year":"2003"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"Luesse","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib42","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1523\/JNEUROSCI.3701-11.2012","article-title":"Micro-positron emission tomography imaging of rat brain metabolism during expression of contextual conditioning","volume":"32","author":"Luyten","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1109\/42.563664","article-title":"Multimodality image registration by maximization of mutual information","volume":"16","author":"Maes","year":"1997","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib46","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0306-4522(02)00013-1","article-title":"Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance","volume":"111","author":"Metz","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0270(02)00012-2","article-title":"Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination","volume":"115","author":"Metz","year":"2002","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ajmg.a.33911","article-title":"Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume","volume":"155A","author":"Nicolas","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib50","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","article-title":"Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum","volume":"28","author":"Nishi","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib51","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/ejn.12202","article-title":"Decreased expression of GLT-1 in the R6\/2 model of Huntington's disease does not worsen disease progression","volume":"38","author":"Petr","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib52","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.neurobiolaging.2011.09.026","article-title":"Increased regional cerebral glucose uptake in an APP\/PS1 model of Alzheimer's disease","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1088\/0031-9155\/43\/4\/027","article-title":"High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner","volume":"43","author":"Qi","year":"1998","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib54","doi-asserted-by":"crossref","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD","volume":"8","author":"Rattray","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib55","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib57","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.410380605","article-title":"Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients","volume":"38","author":"Richfield","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0004-282X2006000100002","article-title":"Clinical presentation of juvenile Huntington disease","volume":"64","author":"Ruocco","year":"2006","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","article-title":"Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington's disease","volume":"12","author":"Samadi","year":"2013","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nbd.2008.09.016","article-title":"Voxel-based morphometry in the R6\/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry","volume":"33","author":"Sawiak","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(03)02754-9","article-title":"Immunohistochemical localization of PDE10A in the rat brain","volume":"985","author":"Seeger","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib63","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/cne.21774","article-title":"Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei","volume":"509","author":"Suarez","year":"2008","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib65","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in\u00a0vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib66","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/nimg.2001.1047","article-title":"Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design","volume":"16","author":"Van Laere","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib67","first-page":"11","article-title":"Automated quantitative gait analysis in animal models of movement disorders","volume":"9","author":"Vandeputte","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib68","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.06.010_bib69","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.physbeh.2008.10.020","article-title":"Age, experience and genetic background influence treadmill walking in mice","volume":"96","author":"Wooley","year":"2009","journal-title":"Physiol. Behav."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014004291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014004291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T11:41:33Z","timestamp":1565523693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014004291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0197458014004291"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.06.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in\u00a0vivo in R6\/2 Huntington mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}